IGM Biosciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IGM Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • IGM Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $152K, a 103% increase year-over-year.
  • IGM Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $115M, a 47.5% decline from 2022.
  • IGM Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $219M, a 8760% increase from 2021.
  • IGM Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.48M, a 98.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $115M -$104M -47.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $219M +$217M +8760% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $2.48M -$212M -98.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 $215M -$67.5M -23.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $282M +$260M +1164% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $22.3M +$14.3M +177% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $8.07M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.